Excess Weight, Obesity, Diabetes (Type-2), and Clinical
Complications
	 Volume 1 - Issue 1
		
		Gundu H R Rao*
		
		
		
		      - 
                
				Author Information
Open or Close
                
				
				
		- Laboratory Medicine and Pathology, University of Minnesota, USA
 *Corresponding author:  Gundu H R Rao, Laboratory Medicine and Pathology, Lillehei Heart Institute, University of Minnesota, 12500 Park
Potomac Ave Unit 306N, Potomac, MD 20854, USA
				 
 
 
 
 
			
			
			
				Received: February 13, 2017;   Published: February 16, 2018
             
      DOI:  10.32474/ADO.2018.01.000101
			 
			   		
			   
			    Full Text
			   Full Text
			   
			   
			    PDF
			   PDF
			   
			   
				To view the Full Article    Peer-reviewed Article PDF
		
		Abstract
According to the National Institutes of Diabetes, Digestive
and Kidney Diseases of the National Institute of Health, USA,
approximately two-thirds of all adults in the USA (167 million), are
overweight and a third is obese. The World Health Organization
(WHO) estimates that there are 1.3 billion overweight adults
globally. Of these 300 million are clinically obese. The global
increase in incidence of type-2 diabetes among adults has more
than doubled since 1980, from 153 million to 422 million people,
according to a study donein 2014, involving 2.7 million people from
around the world. These numbers and statistics keep changing
every year, in view of the rapidity with which these twin epidemics
are increasing worldwide.Cardiometabolic diseases (CMDs),
including hypertension, obesity and Type-2 diabetes, are a growing
concern and have become an epidemic worldwide [1-9]. In view
of this global concern, professionals and professional societies
are putting out current revised guidelines to manage better, these
diseases.
   
 
        
       
		
				    
        
           Editorial|
References|